New treatments for hepatitis C: The protease inhibitors

Research output: Contribution to journalReview ArticleOtherpeer-review


The first-generation hepatitis C virus protease inhibitors telaprevir and boceprevir recently became available in Australia for treating chronic genotype 1 hepatitis C. They significantly improve treatment success rates.

Original languageEnglish
Pages (from-to)73-75
Number of pages3
JournalMedicine Today
Issue number11
Publication statusPublished - Nov 2012

Cite this